Sufentanil Sublingual Tablet 30 mcg for the Management of Pain Following Abdominal Surgery: A Randomized, Placebo-Controlled, Phase-3 Study

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

<p class="first" id="d9828328e123">Results from a phase-3, prospective, randomized, double-blind, placebo-controlled trial evaluating sufentanil sublingual tablet 30 mcg (SST) for the management of pain after ambulatory abdominal surgery are presented. </p>

Related collections

Author and article information

Journal

Title: Pain Practice

Abbreviated Title: Pain Pract

Publisher: Wiley

ISSN: 15307085

Publication date Created: September 2017

Publication date (Print): September 2017

Publication date (Electronic): February 10 2017

Volume: 17

Issue: 7

Pages: 848-858

Affiliations

[1 ]Department of Anesthesiology; Memorial Hermann Memorial City Medical Center; Houston Texas U.S.A

[2 ]Research Department; Hermann Drive Surgical Hospital; Houston Texas U.S.A

[3 ]Department of Anesthesiology; Shoals Medical Trials, Inc; Sheffield Alabama U.S.A

[4 ]Lotus Clinical Research; Pasadena California U.S.A

[5 ]Medical and Clinical Affairs; AcelRx Pharmaceuticals; Redwood City California U.S.A

Article

DOI: 10.1111/papr.12531

PubMed ID: 27781372

SO-VID: 57e1c595-09a9-428b-a95d-d49aecc5cfe6

License:

http://doi.wiley.com/10.1002/tdm_license_1.1

http://creativecommons.org/licenses/by-nc/4.0/

History

Data availability:

Comments

Comment on this article

scite_

Cited by 14

See all cited by